As a result, a market for cheaper, off-brand versions of their active ingredients — semaglutide and tirzepatide — has ...

Compounded GLP-1s are no longer to be sold following the FDA announcement that the shortage of semaglutide and tirzepatide ended.

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

Compounding pharmacies, that produced the weight loss drugs at a fraction of their brand name price, are being forced to stop ...

(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...

The maker of weight loss drugs Ozempic and Wegovy broke rules around the advertising and marketing of its medication to ...

The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or ...